Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Intratumoral Injections of VLPONC-01 in Head and Neck Cancer

NCT06736379 is registered in ClinicalTrials.gov with VLP Therapeutics as lead sponsor.

NCT NCT06736379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06736379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Intratumoral Injections of VLPONC-01 in Head and Neck Cancer
Lead sponsor
VLP Therapeutics
Phase
Phase 1
Overall status
Recruiting
Start date
May 13, 2025
Completion date
December 30, 2027
Enrollment
41 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer, head and neck cancers- squamous cell, head and neck squamous cell cancer, head neck cancer, hnscc, oral cavity, oral cavity carcinoma, scc - squamous cell carcinoma, scchn, solid tumors, squamous cell carcinoma of the head and neck, squamous cell carcinoma, head and neck, squamous cell head and neck carcinoma